Literature DB >> 17932820

A new cytotoxic agent from solid-state fermented mycelium of Antrodia camphorata.

Tzong-Huei Lee1, Ching-Kuo Lee, Wan-Lin Tsou, Sheng-Yung Liu, Mao-Tien Kuo, Wu-Che Wen.   

Abstract

Antroquinonol ( 1), an ubiquinone derivative, was isolated from the solid-state fermented mycelium of Antrodia camphorata (Polyporaceae, Aphyllophorales), a parasitic fungus indigenous to Taiwan. The structure of compound 1 was elucidated by the analysis of their spectroscopic data. Its cytotoxic activities were evaluated against MCF-7, MDA-MB-231 (human breast carcinoma), Hep3B, HepG2 (human liver carcinoma) and DU-145, LNCaP (human prostate carcinoma) cell lines, and the IC (50) values ranged from 0.13 +/- 0.02 to 6.09 +/- 0.07 microM.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17932820     DOI: 10.1055/s-2007-990232

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  30 in total

1.  Ideality in Context: Motivations for Total Synthesis.

Authors:  David S Peters; Cody Ross Pitts; Kyle S McClymont; Thomas P Stratton; Cheng Bi; Phil S Baran
Journal:  Acc Chem Res       Date:  2021-01-21       Impact factor: 22.384

2.  A phase I multicenter study of antroquinonol in patients with metastatic non-small-cell lung cancer who have received at least two prior systemic treatment regimens, including one platinum-based chemotherapy regimen.

Authors:  Yu-Chin Lee; Ching-Liang Ho; Woei-Yau Kao; Yuh-Min Chen
Journal:  Mol Clin Oncol       Date:  2015-09-15

3.  Antrodia Cinnamomea Reduces Carbon Tetrachloride-induced Hepatotoxicity In Male Wister Rats.

Authors:  Yung-Luen Shih; Ming-Fang Wu; Ching-Hsiao Lee; Ming-Yang Yeh; Jason Chou; Jia-You Liu; Hsu-Feng Lu; Yi-Ping Huang; Nien-Chieh Liao; Jing-Gung Chung
Journal:  In Vivo       Date:  2017 Sep-Oct       Impact factor: 2.155

4.  Synthetic (+)-antroquinonol exhibits dual actions against insulin resistance by triggering AMP kinase and inhibiting dipeptidyl peptidase IV activities.

Authors:  C Y Hsu; R S Sulake; P-K Huang; H-Y Shih; H-W Sie; Y-K Lai; C Chen; C F Weng
Journal:  Br J Pharmacol       Date:  2015-01       Impact factor: 8.739

5.  Nanoparticles of Antroquinonol-Rich Extract from Solid-State-Cultured Antrodia cinnamomea Improve Reproductive Function in Diabetic Male Rats.

Authors:  Zwe-Ling Kong; Jia-Ling He; Sabri Sudirman; Mao-Tien Kuo; Song Miao; Ke-Liang B Chang; David Tsou
Journal:  Int J Nanomedicine       Date:  2020-06-15

6.  Inhibition of Cell Growth and Induction of Apoptosis by Antrodia camphorata in HER-2/neu-Overexpressing Breast Cancer Cells through the Induction of ROS, Depletion of HER-2/neu, and Disruption of the PI3K/Akt Signaling Pathway.

Authors:  Chuan-Chen Lee; Hsin-Ling Yang; Tzong-Der Way; K J Senthil Kumar; Ying-Chen Juan; Hsin-Ju Cho; Kai-Yuan Lin; Li-Sung Hsu; Ssu-Ching Chen; You-Cheng Hseu
Journal:  Evid Based Complement Alternat Med       Date:  2012-06-03       Impact factor: 2.629

7.  Apoptotic Cell Death and Inhibition of Wnt/β-Catenin Signaling Pathway in Human Colon Cancer Cells by an Active Fraction (HS7) from Taiwanofungus camphoratus.

Authors:  Chi-Tai Yeh; Chih-Jung Yao; Jiann-Long Yan; Shuang-En Chuang; Liang-Ming Lee; Chien-Ming Chen; Chuan-Feng Yeh; Chi-Han Li; Gi-Ming Lai
Journal:  Evid Based Complement Alternat Med       Date:  2011-03-09       Impact factor: 2.629

8.  New Anti-Inflammatory Aromatic Components from Antrodia camphorata.

Authors:  Yu-Chang Chen; His-Lin Chiu; Che-Yi Chao; Wen-Hsin Lin; Louis Kuoping Chao; Guan-Jhong Huang; Yueh-Hsiung Kuo
Journal:  Int J Mol Sci       Date:  2013-02-26       Impact factor: 5.923

9.  The Antitumor Activity of Antrodia camphorata in Melanoma Cells: Modulation of Wnt/β-Catenin Signaling Pathways.

Authors:  You-Cheng Hseu; Hsiao-Tung Tsou; K J Senthil Kumar; Kai-Yuan Lin; Hsueh-Wei Chang; Hsin-Ling Yang
Journal:  Evid Based Complement Alternat Med       Date:  2012-09-25       Impact factor: 2.629

10.  Review of Pharmacological Effects of Antrodia camphorata and Its Bioactive Compounds.

Authors:  Madamanchi Geethangili; Yew-Min Tzeng
Journal:  Evid Based Complement Alternat Med       Date:  2011-01-03       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.